1171825-24-3

Basic information

• Product Name: 4-(2-bromophenyl)pyrrolidin-2-one
• Synonyms: 4-(2-bromophenyl)pyrrolidin-2-one
• CAS NO: 1171825-24-3
• Molecular Weight: 240.099
• Mol File: 1171825-24-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 4-(2-bromophenyl)pyrrolidin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-bromophenyl)pyrrolidin-2-one(1171825-24-3)
• EPA Substance Registry System: 4-(2-bromophenyl)pyrrolidin-2-one(1171825-24-3)

Safety Data

• Hazardous Substances Data: 1171825-24-3(Hazardous Substances Data)

Usage

Main Properties

Pyrrolidin-2-one derivative
Contains a bromophenyl group
Used as an intermediate in the synthesis of pharmaceuticals and agrochemicals
Used in the development of organic compounds for various applications in chemistry
May pose health and environmental risks if not handled properly

Chemical compound

4-(2-bromophenyl)pyrrolidin-2-one
Bromine atom attached to a phenyl ring
Intermediate in pharmaceutical and agrochemical synthesis
Handle with care to avoid health and environmental risks

Upstream product

• 6630-33-7 ortho-bromobenzaldehyde 
• 91047-77-7 ethyl (2E)-3-(2-bromophenyl)prop-2-enoate 

Downstream Products

• 1203686-38-7 3-(2-bromophenyl)pyrrolidine 

Relevant articles and documents

NOVEL 6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for mating the compounds.

6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective α1A adrenoceptor partial agonists

Novel pyrroloimidazoles have been identified as potent partial agonists of the α1A adrenergic receptor, with good selectivity over the α1B, α1D and α2A receptor subtypes. Pyrimidine 19 possessed attractive CNS d